Blue Cross Newsletter

April 28, 2010



To: All Blue Cross Contracting Providers

Cindy Garrison, CPC – Education/Communication Coordinator
Institutional Relations
Blue Cross and Blue Shield of Kansas, Inc.
An Independent Licensee of the Blue Cross and Blue Shield Association


New HCPCS Codes Effective April 1, 2010

Three new HCPCS codes (listed below) were created for use effective April 1, 2010.  Because of the similarity between these codes and CPT code 87390, BCBSKS will reimburse G0432, G0433, and G0435 at the same payment rate as 87390, as stipulated in your provider agreement.



  • G0432

Infectious agent antigen detection by enzyme immunoassay (EIA) technique, qualitative or semi-quantitative, multiple-step method, HIV-1 or HIV-2, screening

  • G0433

Infectious agent antigen detection by enzyme-linked immunosorbent assay (ELISA) technique, antibody, HIV-1 or HIV-2, screening

  • G0435

Infectious agent antigen detection by rapid antibody test of oral mucosa transudate, HIV-1 or HIV-2, screening

HCPCS code G9147 is also effective April 1, 2010.

  • G9147

Outpatient Intravenous Insulin Treatment (OIVIT) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (UUN); and/or, arterial, venous or capillary glucose; and/or potassium concentration

This code is considered experimental and investigational.  The charges will be denied as a provider write-off unless the provider obtains a Notice of Personal Financial Obligation (NOPFO) signed by the patient.  If you obtain a NOPFO, you do not need to actually submit the NOPFO with the claim.  You can append modifier GA to the HCPCS code and submit the claim electronically.  The modifier should immediately follow the procedure code, with no space between.  The waiver is retained in the patient's file.  By obtaining a signed NOPFO, charges will be denied as the patient’s responsibility.

If you have any questions, please contact your provider consultant.